Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dna X (SONM) Other Working Capital Changes (2018 - 2025)

Dna X (SONM) has disclosed Other Working Capital Changes for 8 consecutive years, with -$1.4 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Other Working Capital Changes fell 10.06% year-over-year to -$1.4 million, compared with a TTM value of $2.0 million through Sep 2025, up 3093.65%, and an annual FY2024 reading of $2.9 million, up 6755.81% over the prior year.
  • Other Working Capital Changes was -$1.4 million for Q3 2025 at Dna X, down from $586000.0 in the prior quarter.
  • Across five years, Other Working Capital Changes topped out at $2.8 million in Q4 2024 and bottomed at -$1.4 million in Q3 2025.
  • Average Other Working Capital Changes over 5 years is $115682.5, with a median of $3000.0 recorded in 2025.
  • Peak annual rise in Other Working Capital Changes hit 4653.23% in 2024, while the deepest fall reached 16338.99% in 2024.
  • Year by year, Other Working Capital Changes stood at -$1.1 million in 2021, then surged by 79.17% to -$235000.0 in 2022, then skyrocketed by 73.62% to -$62000.0 in 2023, then soared by 4653.23% to $2.8 million in 2024, then tumbled by 149.59% to -$1.4 million in 2025.
  • Business Quant data shows Other Working Capital Changes for SONM at -$1.4 million in Q3 2025, $586000.0 in Q2 2025, and $3000.0 in Q1 2025.